Abstract
Black communities have been disproportionately impacted by Coronavirus Disease 2019 (COVID-19) in Canada, in terms of both number of infections and mortality rates. Yet, according to early studies, vaccine hesitancy appears to be higher in Black communities. The purpose of this systematic review is to examine the prevalence and factors associated with vaccine hesitancy in Black communities in Canada. Peer-reviewed studies published from 11 March 2020 to 26 July 2022, were searched through eleven databases: APA PsycInfo (Ovid), Cairn.info, Canadian Business & Current Affairs (ProQuest), CPI.Q (Gale OneFile), Cochrane CENTRAL (Ovid), Embase (Ovid), Érudit, Global Health (EBSCOhost), MEDLINE (Ovid), and Web of Science (Clarivate). Eligible studies were published in French or English and had empirical data on the prevalence or factors associated with vaccine hesitancy in samples or subsamples of Black people. Only five studies contained empirical data on vaccine hesitancy in Black individuals and were eligible for inclusion in this systematic review. Black individuals represented 1.18% (n = 247) of all included study samples (n = 20,919). Two of the five studies found that Black individuals were more hesitant to be vaccinated against COVID-19 compared to White individuals, whereas the other three found no significant differences. The studies failed to provide any evidence of factors associated with vaccine hesitancy in Black communities. Despite national concerns about vaccine hesitancy in Black communities, a color-blind approach is still predominant in Canadian health research. Of about 40 studies containing empirical data on vaccine hesitancy in Canada, only five contained data on Black communities. None analyzed factors associated with vaccine hesitancy in Black communities. Policies and strategies to strengthen health research in Black communities and eliminate the color-blind approach are discussed.
Funder
Canadian Institutes of Health Research
Public Health Agency of Canada
Subject
Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology
Reference51 articles.
1. Health equity and COVID-19: Global perspectives;Int. J. Equity Health,2020
2. (2022, September 13). Public Health Agency of Canada The Impact of COVID-19 on Racialized Communities—Canada.ca. Available online: https://www.canada.ca/en/public-health/news/2021/02/cpho-sunday-edition-the-impact-of-covid-19-on-racialized-communities.html.
3. Ethnic and racial disparities in COVID-19-related deaths: Counting the trees, hiding the forest;BMJ Glob. Heal.,2020
4. Social inequalities and collateral damages of the COVID-19 pandemic: When basic needs challenge mental health care;Int. J. Public Health,2020
5. Racial Disproportionality in COVID Clinical Trials;N. Engl. J. Med.,2020
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prevalence and Correlates of Intimate Partner Violence Among Women and Men in Mexico: A Systematic Review and Meta-analysis;Trauma, Violence, & Abuse;2024-09-13
2. Resilience throughout COVID-19: Unmasking the realities of COVID-19 and vaccination facilitators, barriers, and attitudes among Black Canadians;PLOS ONE;2024-08-20
3. COVID-19 vaccine acceptance and uptake among caregivers of children aged 5–11 years in Ontario, Canada: A cross-sectional survey;Vaccine;2024-07
4. COVID‐19 vaccine mistrust, health literacy, conspiracy theories, and racial discrimination among a representative ethnically diverse sample in Canada: The vulnerability of Arab, Asian, Black, and Indigenous peoples;Journal of Medical Virology;2024-07
5. Venous thromboembolism in Black COVID-19 patients in a minority context compared to White, Asian and other racialized patients: A systematic review and meta-analysis;Thrombosis Research;2024-06